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Essentials
• Decision rules for pulmonary embolism are used indiscriminately despite possible sex-differences.
• Various pre-imaging diagnostic algorithms have been investigated in several prospective studies.
• When analysed at an individual patient data level the algorithms perform similarly in both sexes.
• Estrogen use and male sex were associated with a higher prevalence in suspected pulmonary embolism.
Summary. Background:
In patients suspected of pulmonary embolism (PE), clinical decision rules are combined with D-dimer testing to rule out PE, avoiding the need for imaging in those at low risk. Despite sex differences in several aspects of the disease, including its diagnosis, these algorithms are used indiscriminately in women and men. Objectives: To compare the performance, defined as efficiency and failure rate, of three preimaging diagnostic algorithms for PE between women and men: the Wells rule with fixed or with age-adjusted D-dimer cut-off, and a recently validated algorithm (YEARS). A secondary aim was to determine the sex-specific prevalence of PE. Methods: Individual patient data were obtained from six studies using the Wells rule (fixed D-dimer, n = 5; age adjusted, n = 1) and from one study using the YEARS algorithm. All studies prospectively enrolled consecutive patients with suspected PE. Main outcomes were efficiency (proportion of patients in which the algorithm ruled out PE without imaging) and failure rate (proportion of patients with PE not detected by the algorithm). Outcomes were estimated using (multilevel) logistic regression models. Results: The main outcomes showed no sex differences in any of the separate algorithms. With all three, the prevalence of PE was lower in women (OR, 0.66, 0.68 and 0.74). In women, estrogen use, adjusted for age, was associated with lower efficiency and higher prevalence and D-dimer levels. Conclusions:
The investigated pre-imaging diagnostic algorithms for patients suspected of PE show no sex differences in performance. Male sex and estrogen use are both associated with a higher probability of having the disease.
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Background
Diagnosing pulmonary embolism (PE) is a daily clinical challenge in which there needs to be a balance between missing the potentially fatal diagnosis and the exposure to imaging tests of many patients with a low likelihood of the disease. Hence, clinical decision rules are combined with D-dimer plasma levels to select patients who should undergo imaging of the pulmonary vasculature [1] [2] [3] . The performance of these pre-imaging diagnostic algorithms can be viewed in terms of their capacity to reduce the need for imaging tests (i.e. efficiency), while at the same time minimizing the number of missed cases of PE (i.e. safety). PE has various sex-dependent aspects. Differences between women and men in presenting signs and symptoms have been reported [4] [5] [6] . Oral estrogen use is an important women-specific risk factor for PE [7] . Furthermore, although the prevalence rate appears similar in both sexes at 0.3-0.5 per thousand person-years [8] [9] [10] , women make up a larger proportion of the cohorts of patients suspected of PE in the various diagnostic studies [11, 12] . This implies a lower prevalence among women with clinically suspected PE, which could impact the performance of diagnostic tests.
Diagnostic algorithms for PE are applied in clinical practice without taking sex into account. Yet in patients suspected of deep venous thrombosis (DVT), a meta-analysis found that a clinical decision rule performed differently in women compared to men [13] . Another individual patient data meta-analysis on the diagnostic management of DVT also suggested a possible sex difference in efficiency (women 32 [14] . For PE, a metaanalysis of three studies showed that the Geneva score and revised Geneva score have comparable performance in women and men [4] . However, when the three-level Wells score was retrospectively calculated in these cohorts, there was a significant difference in risk stratification between women and men.
The aim of the current study was to compare the performance, in terms of efficiency and failure rate, of three pre-imaging diagnostic algorithms for PE in women and men: the Wells rule combined with a fixed [1] or ageadjusted [2] D-dimer cut-off and the recently validated YEARS algorithm, in which the threshold of D-dimer is increased when no YEARS items are present [3] . A secondary aim was to evaluate the sex-specific sensitivity, specificity and prevalence in patients suspected of PE. We also investigated two subgroups: women younger than 50 years, in whom avoiding unnecessary imaging is especially important because of high radiation sensitivity of breast tissue [15] ; and women using estrogen, because estrogen use raises D-dimer levels [16, 17] , potentially affecting algorithm performance.
Methods

Data sources and study selection
The current study was conducted using individual patient data from seven studies investigating one of the algorithms mentioned above. Six studies were identified previously in a systematic review, which aimed at identifying all studies in which the diagnostic management of PE was guided by the dichotomized Wells rule followed by quantitative D-dimer testing [2, 3, [18] [19] [20] [21] [22] [23] . In brief, MEDLINE and EMBASE were searched from the year of introduction of the Wells score (1 January 1998) up to 13 February 2016, combining terms for 'pulmonary embolism' and 'D-dimer'. The search was restricted to original studies in adults and used an adapted search filter for diagnostic and prognostic studies without language restrictions [24] . The full search strategy was published previously [23] . The seventh study was the initial and thus far only prospective study evaluating the YEARS algorithm, which has recently been published [3] . All studies prospectively included consecutive hemodynamically stable adult patients with a clinical suspicion of PE. In all studies, participants were followed for at least 3 months for symptomatic fatal or non-fatal venous thromboembolism (VTE).
Authors of the included original studies provided patient-level data on the following items: demographics, VTE risk factors, items of the applied decision rules, Ddimer concentrations, imaging results, anticoagulant use for other reasons than VTE, estrogen use, and completeness and outcome of follow-up. The provided data were checked against the published studies by reconstructing the baseline characteristics tables. Death was considered a case of PE if PE could not be excluded as a cause of death.
Pre-imaging diagnostic algorithms
Three pre-imaging diagnostic algorithms for PE were evaluated, which have been described in detail previously [1] [2] [3] . In brief, the dichotomized Wells rule is a seven-item scoring system, classifying patients with 4 points or less as 'PE unlikely' and those with more than 4 points as 'PE likely' [1] . D-dimer testing is performed in 'PE unlikely' patients, safely ruling out PE in those with a concentration of 500 lg L À1 or less. Patients with higher D-dimer concentrations and 'PE likely' patients should undergo pulmonary imaging. For patients over 50 years, this strategy can be adapted by adjusting the positivity threshold of D-dimer by multiplying the age of the patient by 10 lg L À1 [2] . Recently, the YEARS algorithm has been validated, consisting of a three item decision rule with simultaneous D-dimer testing [3] . Patients are assigned one point for signs of DVT, hemoptysis and PE being the most likely diagnosis. Patients with a combination of either 0 points and D-dimer ≥ 1000 ng mL À1 or ≥ 1 points and D-dimer ≥ 500 ng mL À1 are referred for pulmonary imaging.
Primary and secondary endpoints
The main outcome measures were efficiency and failure rate for the separate algorithms. Efficiency was defined as the proportion of all patients in whom the algorithm indicated that imaging was not required. We used an intention-to-diagnose approach; that is, the result of the algorithm was used as the outcome rather than the actual clinical management. The failure rate was defined as the proportion of patients with VTE, either at baseline or during 3-month follow-up, within the group of patients in whom imaging was not indicated according to the algorithm. Sensitivity was calculated by the proportion of patients with VTE at baseline or during 3-month followup in whom the algorithm indicated a need for imaging. Specificity was the proportion of patients without VTE in whom the algorithm did not indicate a need for imaging.
Prevalence was defined as the proportion of all patients who had a VTE at baseline or during follow-up.
Analysis
Patients were only included in the analysis of the algorithm they were originally managed with (i.e. we did not calculate outcomes of the additional algorithms in a posthoc manner for analysis purposes). Data from patients in the included studies who were not managed according to one of the three algorithms were omitted. Patients who received anticoagulation for reasons other than VTE were excluded from the failure rate analysis, as clinical followup could not be relied upon to identify VTE in these patients.
In the primary analysis, we compared efficiency and failure rate between women and men. In subgroup analyses we compared women using estrogen with women not using estrogen, and women younger than 50 years with men younger than 50 years. The ADJUST-PE study was excluded from the latter analysis as the threshold increase in this algorithm starts at age 50 years [2] . As one of the included studies (Mos et al. [18] ) exclusively enrolled patients with suspected recurrent PE, and men have a significantly higher risk of recurrence compared with women [25] , we performed a sensitivity analysis for prevalence omitting this study.
We dealt with missing data through multiple imputation with 10 iterations, performed separately in each study as described previously [23] . We assumed a missing at random pattern. All baseline and outcome data were used in the imputation model.
We calculated proportions, odds ratios (ORs) and 95% confidence intervals (95% CIs) using logistic regression models with sex as the independent variable. For the Wells rule combined with fixed D-dimer testing, we performed a single-stage individual patient data meta-analysis, with a random intercept effect for study to account for study level clustering. The models for the Wells rule combined with age-adjusted D-dimer testing and the YEARS algorithm were based on single studies. Models were run on 10 imputed datasets and results combined according to the Rubin rule [26] .
We tested the association between estrogen use and Ddimer level in pooled data from all female participants. D-dimer levels were not imputed for this particular analysis. A multilevel linear regression model with a random intercept effect for study, adjusted for age and the presence of VTE, was used. The P-value was obtained by likelihood ratio test of the full model against the reduced model with the estrogen variable omitted.
Analyses were performed in R version 3.3.3 (R Foundation for Statistical Computing; www.R-project.org). We used the mice package (version 2.22) for multiple imputation and the lme4 package (version 1.1-10) for multilevel logistic regression modelling.
Results
Characteristics of included studies
The characteristics of the included studies are summarized in Table 1 . Five studies evaluated the Wells rule with fixed D-dimer cut-off, one the Wells rule with ageadjusted D-dimer cut-off, and one the YEARS algorithm. Sample sizes ranged from 281 to 3465. The proportion of women ranged from 50.6% to 62.6%. The prevalence of PE ranged from 13% to 42%. Estrogen use in female patients ranged from 2.5% to 23.1%.
Algorithm performance and prevalence in women and men
For all three algorithms, the efficiency was comparable in women and men (Table 2) . Similarly, the failure rate was not different in men compared with women for the Wells rule with fixed D-dimer testing and for the YEARS algorithm. For the Wells rule with age-adjusted D-dimer testing, there were two failures, both were women. When data from the studies on different algorithms were pooled, the overall efficiency was higher in women with an OR of 1.11 (95% CI, 1.02-1.2). There was no statistically significant difference in failure rate.
The prevalence of PE was lower in women than in men ( Table 2 ). The ORs for PE for women compared with men were 0.68 (95% CI, 0.60-0.78) in the pooled studies investigating the Wells rule with fixed D-dimer, 0.74 (95% CI, 0.58-0.94) for age-adjusted D-dimer and 0.66 (95% CI, 0.55-0.81) for the YEARS algorithm. These differences remained statistically significant after adjusting for age. The pooled unadjusted overall prevalence was 18.7% in women and 25.1% in men. In the sensitivity analysis of the Wells rule with fixed D-dimer excluding the study by Mos et al., the prevalence was 17.6% for women and 23.7% for men, corresponding to an OR of 0.69 (95% CI, 0.60-0.78). Figure 1 represents the model-predicted efficiency and prevalence of the three algorithms, according to age and stratified by sex. The figure demonstrates a lower prevalence in women for each algorithm, but not different efficiencies. Although the efficiency curves for women and men intersect, there was no statistical evidence of interaction between age and sex on efficiency. Finally, none of the three algorithms showed a difference between women and men in sensitivity or in specificity (Table 3) .
Subgroup analyses
In the subgroup of patients aged younger than 50 years, efficiency was not different between women and men (Table 4) . Efficiency was lower in women using estrogen compared with women not using estrogen for the Wells rule with fixed D-dimer (age-adjusted OR, 0.76; 95% CI, 0.61-0.93) and YEARS algorithm (age-adjusted OR, 0.49; 95% CI, 0.37-0.64), adjusting for age. There was no statistically significant difference for the Wells rule with age-adjusted D-dimer (OR, 0.66; 95% CI, 0.29-1.5). The prevalence, adjusted for age, was higher in estrogen users with all three algorithms (Table 4) . Estrogen-using women had higher D-dimer levels, with a mean difference of 144 lg L À1 (P = 0.037), adjusted for age and VTE diagnosis.
Discussion
In the current analysis we evaluated the sex-specific prevalence and performance of three widely used pre-imaging diagnostic algorithms for PE using individual patient data from seven prospective management studies. We found a consistently lower prevalence in women suspected of having PE as compared with men. This is congruent with the observation from the literature that the majority of participants in diagnostic studies are women, despite their PE prevalence rates being equal to those men [8] [9] [10] [11] [12] . The higher proportion of women in all included studies is also in line with this. Women suspected of PE thus have a lower risk of actually having the disease than men. Both the efficiency and failure rate of the different algorithms were comparable between women and men. This similar efficiency despite a lower prevalence in women might suggest a lower specificity: there were fewer cases of PE in the women, yet the algorithm indicated the need for imaging as often as in men. However, in all three algorithms the specificity did not vary with sex. This can *Odds of algorithm indicating that imaging was not required, women vs. men. †Odds of VTE, either at baseline or during 3-month follow-up, within the group of patients in whom imaging was not indicated according to the algorithm, women vs. men. ‡Odds of VTE at baseline or follow-up, women vs. men. 
15.5%
*Sample sizes reflect the number of patients that could be included in the current study. †By t-test.
be explained by the fact that even though there was no statistical difference in efficiency, numerically the efficiency differed slightly. Indeed, when data from studies on the separate algorithms were pooled we found a higher efficiency in women. Substantial differences in prevalence translate into relatively small differences in efficiency. The apparent incongruity between the different prevalences and no difference in efficiency, is thus not explained by a difference in specificity but rather reflects a marginally higher efficiency in women, as should be expected with the lower prevalence. A lower prevalence in women was not observed in a meta-analysis investigating two other diagnostic algorithms for PE [4] . One possible explanation for this discrepancy is the higher age in the included cohorts compared with the current study. In a post-hoc analysis of the PIOPED study the prevalence of PE was lower in women aged 50 years or younger compared with men of the same age, but this difference disappeared at higher ages [27] . In a later PE diagnostic management study with a mean age of participants comparable to that in the current study, men indeed had a higher prevalence than women [28] .
Efficiency is especially important in younger women. First, these women do not benefit from the increase in efficiency of the algorithm with age-adjusted D-dimer cutoff, in which the D-dimer positivity threshold starts to increase at the age of 50 years. Second, the risk of radiation-associated breast cancer is higher at lower ages of ionizing radiation exposure [15] . In our subgroup analysis of patients under 50 years, efficiency did not vary with sex. We thus found no indication of a need for a different approach in this important subgroup.
Estrogen use is a well-established risk factor for VTE [7, 29] . D-dimer levels appear to rise after the initiation of oral contraceptives or hormone replacement therapy [16, 17, [30] [31] [32] . Consistent with this observation, in our analysis, women taking estrogen indeed had a higher prevalence of PE, with a corresponding decrease in the efficiency of the algorithms. In an attempt to explain this decreased efficiency, we investigated whether estrogen use was associated with higher D-dimer levels, hypothesizing that exogenous estrogens raise D-dimer levels in the absence of PE, in some cases crossing the positivity threshold and thus lowering the specificity of the algorithm. Estrogen use was indeed associated with increased plasma D-dimer levels, adjusted for age and the presence of a VTE diagnosis. Specificity itself was not affected however (data not shown). We therefore do not conclude that estrogen use affects the performance of the algorithms aside from the elevated prevalence of PE.
The current study contributes to the field of PE diagnosis by reporting the sex-specific performance of the Wells rule with fixed and age-adjusted D-dimer as well as the YEARS algorithm. It includes all published prospective management studies on these PE pre-imaging diagnostic algorithms in the secondary or tertiary care setting. The use of prospectively collected individual patient data, which is now considered the reference standard for metaanalyses [33] , enabled investigation of relevant subgroups and the uniform definition of variables across the various studies. Pooling the results of the five studies investigating the Wells rule with fixed D-dimer provided robust estimates of the performance of this broadly used algorithm.
Given low absolute numbers of failures, the study was not powered to detect potential small sex differences in the failure rate. Nevertheless, the failure rates for both women and men remained well below 3%, which is considered a safe upper limit for the failure rate of a diagnostic test for PE, based on the failure rate of the reference standard of pulmonary angiography [34, 35] . Although there was an overall high homogeneity in study design, individual studies did vary in methods and study population. For example, various D-dimer assays were used. Furthermore, the overall prevalence and the proportion of women varied between studies. In the analyses that pooled multiple studies, random effects were used to incorporate this study-level variability into the model. Nevertheless, this heterogeneity makes careful interpretation of pooled results necessary, especially of results on combined algorithms because the algorithms are in fact distinct diagnostic tests.
We chose efficiency and safety as primary outcome measures in the current study, despite the fact that the prevalence influences these parameters. Alternatively, one might focus on sensitivity and specificity. A limitation in the estimation of these parameters, however, is the risk of differential verification bias. In the included studies, patients with a positive algorithm result received a CT scan, whereas patients with a negative algorithm did not. This differential verification can be a source of bias for sensitivity and specificity [36] . In addition, sensitivity and specificity tend to vary with prevalence of disease as well [37] . These parameters are thus presented as secondary outcomes and should be interpreted with caution.
Given the widespread use of the Wells rule for PE diagnosis and the recent reports that the age-adjusted Ddimer and YEARS algorithm are more efficient than traditional diagnostic algorithms, the question of sex differences in algorithm performance is relevant in the context of individualized patient care. The algorithms perform equally well in women and men. Men do have a higher prevalence than women when clinically suspected of having PE, and the same goes for women using estrogen as compared with non-users. Although this should not lead clinicians to deviate from an established diagnostic strategy in these patient groups, the findings can inform future studies on diagnostic algorithms, which may investigate the added value of sex and estrogen use as risk stratifiers and D-dimer cut-off modifiers for patients suspected of PE. 
